logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Folate Analog Metabolic Inhibitor class drugs

    FiltersReset Filters
    10 results

    • folotyn

      (pralatrexate)
      Acrotech Biopharma Inc
      Usage: FOLOTYN is indicated for treating patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Its approval is based on overall response rates, with continued approval dependent on confirmation of clinical benefits in future trials.

    • jylamvo

      (Methotrexate)
      SHORLA ONCOLOGY INC.
      Usage: JYLAMVO is indicated for treating acute lymphoblastic leukemia in adults and pediatric patients, mycosis fungoides, relapsed non-Hodgkin lymphomas, rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis in pediatrics, and severe psoriasis in adults.

    • methotrexate

      (Methotrexate)
      Chartwell RX, LLC
      Usage: Methotrexate tablets are indicated for treating neoplastic diseases (acute lymphoblastic leukemia, mycosis fungoides, relapsed non-Hodgkin lymphomas), rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis in pediatric patients, and severe psoriasis in adults.

    • methotrexate sodium

      (Methotrexate Sodium)
      Hikma Pharmaceuticals USA Inc.
      Usage: Methotrexate Tablets are indicated for the treatment of various conditions, including acute lymphoblastic leukemia, mycosis fungoides, relapsed non-Hodgkin lymphomas, rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis in pediatric patients, and severe psoriasis in adults.

    • otrexup

      (methotrexate)
      Antares Pharma, Inc.
      Usage: Otrexup is indicated for managing severe, active rheumatoid arthritis in adults and children with polyarticular juvenile idiopathic arthritis, as well as for the symptomatic control of severe psoriasis in adults unresponsive to other treatments. It is not for neoplastic diseases.

    • otrexup

      (methotrexate)
      Otter Pharmaceuticals, LLC
      Usage: Otrexup is indicated for managing severe, active rheumatoid arthritis in adults and children with polyarticular juvenile idiopathic arthritis, unresponsive to first-line therapies. It is also approved for adults with severe, recalcitrant psoriasis unresponsive to other treatments. It is not intended for neoplastic disease treatment.

    • pemetrexed

      (Pemetrexed disodium)
      Sandoz Inc.
      Usage: Pemetrexed Injection is indicated for the initial treatment of metastatic non-squamous non-small cell lung cancer (NSCLC), in combination with chemotherapy or as a maintenance single agent, and for malignant pleural mesothelioma in combination with cisplatin for patients not eligible for surgery.

    • pemetrexed

      (Pemetrexed disodium)
      Ingenus Pharmaceuticals, LLC
      Usage: Pemetrexed for Injection is indicated for the initial treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with pembrolizumab or cisplatin, and as a maintenance or single-agent therapy for recurrent NSCLC. It is also used with cisplatin for malignant pleural mesothelioma. Not for squamous NSCLC.

    • rasuvo

      (methotrexate)
      Medexus Pharma Inc.
      Usage: Rasuvo is indicated for managing severe, active rheumatoid arthritis in adults and polyarticular juvenile idiopathic arthritis in children who haven't responded to or are intolerant of first-line therapies. It also treats severe psoriasis in adults unresponsive to other therapies, ensuring proper diagnosis beforehand. Not for neoplastic diseases.

    • xatmep

      (Methotrexate)
      Azurity Pharmaceuticals, Inc.
      Usage: XATMEP is indicated for treating pediatric patients with acute lymphoblastic leukemia (ALL) as part of a chemotherapy regimen, and for managing active polyarticular juvenile idiopathic arthritis (pJIA) in patients unresponsive or intolerant to first-line NSAID therapy.